Upkara, an Ann Arbor, MI-based biomedical technology company, raised $9M in Series A funding.
Backers included Bill Parfet, and Paul Meister.
The company intends to use the funds to accelerate its growth trajectory, and continue to develop and commercialize its technology.
Led by Pravansu Mohanty, Upkara works in the field of biomedical industry with its biopreservation technology that improves access to therapeutics and research tools by enabling ambient temperature storage and transportation. The company is currently collaborating with reagent companies to incorporate its technology into manufacturing processes. Biomolecules stabilized by its process can be stored and shipped at ambient temperatures, reducing waste, increasing efficiency, and improving sustainability. As such, Upkara-stabilized reagents provide cost savings to manufacturers while enhancing customer appeal.
FinSMEs
16/05/2023